MedPath

Effects of lactic acid bacteria intake on perimenopausal men and women on menopause-like symptoms, sleep and biomarkers

Not Applicable
Conditions
Healthy adult
Registration Number
JPRN-UMIN000041472
Lead Sponsor
TTC Co., Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Subjects who have passed more than one year after menopause (2) Subjects with history, treatment history, medication, or health food intake affecting the assessment of climacteric symptoms (3) Subjects with history, treatment history, medication, or health food consumption that affect sleep assessment (4) Subjects who ingest excessively soy products such as natto and soy drinks (5) Subjects who take foods rich in lactic acid bacteria (yogurt, lactic acid bacteria beverages, etc.) at least three times a week (6) Subjects who have had ovarian, uterine or orchiectomy surgery (7) Excessive smokers, alcohol addicts, and subjects with extremely irregular diets (8) Subjects whose overall score of the Pittsburgh Sleep Questionnaire at the pre-examination is less than 3, or more than 10, or who are estimated to have sleep disorders such as insomnia from the answers (9) Subjects whose BMI are 30.0 kg/m^2 or more (10) Subjects who are awakened midway through external factors such as child crying at least twice a week (11) Night and day shift worker or manual laborer (12) Subjects who have under treatment or a history of serious disease (e.g., diabetes, liver disease, kidney disease, or heart disease) and disease to affect the adrenal cortical hormone secretion (13) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (14) Subjects considered unsuitable as subjects based on pre-examination laboratory test values, measurement values, and prostate tumor markers (15) Subjects who have participated in other clinical study within the last one month or have plan to participate other clinical studies (16) Subjects who are pregnant or lactating, or plan to become pregnant or lactate during the study (17) Subjects who are judged as unsuitable for the study by investigator for other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath